Algorae Pharmaceuticals LimitedASX: 1AI

Change of Director's Interest Notice - DH

· Issued by Algorae Pharmaceuticals Limited via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

This filing is a Change of Director's Interest Notice for Algorae Pharmaceuticals Limited, detailing changes in the interests of director David Hainsworth. The notice reports that Hainsworth acquired additional shares through an on-market trade, increasing his indirect interest in Cathedral Estate Pty Ltd. The document outlines the number of securities held before and after the change, including fully paid ordinary shares and performance rights.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced...

Algorae Pharmaceuticals Limited on 6ix

Earlier from Algorae Pharmaceuticals

Later from Algorae Pharmaceuticals

All Algorae Pharmaceuticals news releases